HomePharma

Pharma

Pharma

Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm

Life Sciences Times - 0
Pharma

Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate LP-184’s Phase 1 Clinical Trial in Q2 2023

Life Sciences Times - 0
Pharma

Results of the First Post-Commercial Utilization Review of JELMYTO® Provide New Evidence that Reinforces its Efficacy and Safety in Patients with Low-Grade Upper Tract...

Life Sciences Times - 0
Pharma

Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer

Life Sciences Times - 0
Pharma

Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon...

Life Sciences Times - 0
Pharma

HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603

Life Sciences Times - 0
Pharma

Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease

Life Sciences Times - 0
Pharma

Glycomine Announces First Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG

Life Sciences Times - 0
Pharma

Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1

Life Sciences Times - 0
Pharma

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma

Life Sciences Times - 0
Pharma

PharmaEssentia Establishes a New Research and Development Facility in the Boston Area

Life Sciences Times - 0
Pharma

Biocytogen and Hansoh Pharma Announce an Antibody License Agreement

Life Sciences Times - 0
1...434445...91Page 44 of 91

Most Read